Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Longeveron Inc. | Director | Class A Common Stock | 23.8K | $49.2K | $2.07 | Dec 2, 2024 | Direct |
Longeveron Inc. | Director | Common Stock | 14.9K | $15.8K | $1.06 | Jun 9, 2024 | Direct |
Processa Pharmaceuticals, Inc. | Director | Restricted Stock | 31.2K | Sep 3, 2024 | Direct | ||
Longeveron Inc. | Director | Stock Option (Right to buy) | 12K | Dec 21, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
LGVN | Longeveron Inc. | Dec 2, 2024 | 1 | -$2.59K | 4 | Dec 4, 2024 | Director |
PCSA | Processa Pharmaceuticals, Inc. | Sep 3, 2024 | 1 | $0 | 4 | Sep 18, 2024 | Director |
LGVN | Longeveron Inc. | Aug 15, 2024 | 1 | $0 | 4 | Aug 19, 2024 | Director |
LGVN | Longeveron Inc. | Jun 9, 2024 | 1 | -$133 | 4 | Jun 11, 2024 | Director |
LGVN | Longeveron Inc. | Dec 28, 2023 | 2 | $14.3K | 4 | Jan 2, 2024 | Director |
LGVN | Longeveron Inc. | Dec 21, 2023 | 1 | $0 | 4 | Dec 26, 2023 | Director |
PCSA | Processa Pharmaceuticals, Inc. | Jun 27, 2023 | 3 | $0 | 4 | Jul 24, 2023 | Director |
LGVN | Longeveron Inc. | Jun 9, 2023 | 1 | $0 | 4 | Jun 12, 2023 | Director |
LGVN | Longeveron Inc. | Jun 9, 2023 | 0 | $0 | 3 | Jun 12, 2023 | Director |
PCSA | Processa Pharmaceuticals, Inc. | Feb 9, 2023 | 1 | $10K | 4 | Feb 10, 2023 | Director |
PCSA | Processa Pharmaceuticals, Inc. | Jul 12, 2022 | 1 | $0 | 4 | Jul 14, 2022 | Director |
PCSA | Processa Pharmaceuticals, Inc. | Jul 11, 2022 | 0 | $0 | 3/A | Jul 12, 2022 | Director |